后Tenon囊下注射曲安奈德行23G玻璃体切除术治疗脉络膜脱离型视网膜脱离的疗效
回顾性病例对照研究纳入48例脉络膜脱离型视网膜脱离患者,比较术前后Tenon囊下注射曲安奈德(23眼)与静脉滴注地塞米松(25眼)后行23G玻璃体切除术的疗效。曲安奈德组术前眼压更高、脉络膜脱离高度更低,末次随访最佳矫正视力更优,但术后1和3个月高眼压发生率更高;两组手术复位率差异无统计学意义。
要点
- 曲安奈德组术前眼压高于地塞米松组,脉络膜脱离高度低于地塞米松组。
- 两组手术复位率差异无统计学意义,曲安奈德组末次随访视力更优。
- 曲安奈德组术后1和3个月高眼压发生率更高,末次随访时两组差异无统计学意义。
核心结论
- 后Tenon囊下注射曲安奈德可提高眼压、降低脉络膜脱离高度、改善脉络膜脱离型视网膜脱离患者23G玻璃体切除术后的视力预后,但可能引起术后高眼压。
研究设计与样本
- 回顾性病例对照研究,纳入2012年1月至2015年1月在温州医科大学附属眼视光医院确诊为脉络膜脱离型视网膜脱离并接受23G玻璃体切除术的连续性病例48例(48只眼)。
- 男性16例(16只眼),女性32例(32只眼),平均年龄(57.3±13.9)岁。
- 曲安奈德组23只眼于计划23G玻璃体切除术前5天行后Tenon囊下注射曲安奈德;地塞米松组25只眼于计划玻璃体切除术前3至5天静脉滴注地塞米松10 mg/d。
- 所有患者于入院时、术前、术后1个月、3个月及末次随访行B超、眼压、最佳矫正视力检查,术后随访时间≥6个月。
主要发现
- 术前曲安奈德组眼压为(8.58±3.83)mmHg,高于地塞米松组的(6.70±2.49)mmHg(t=2.032,P<0.05)。
- 术前曲安奈德组脉络膜脱离高度为0.90(0.00,3.84)mm,低于地塞米松组的4.03(1.05,5.38)mm(Z=-2.569,P<0.05)。
- 曲安奈德组手术复位率为95.7%(22/23),地塞米松组为76.0%(19/25),两组差异无统计学意义(χ²=2.304,P=0.129)。
- 末次随访时曲安奈德组最佳矫正视力为0.91±0.54,优于地塞米松组的1.25±0.62(t=-2.034,P=0.048)。
- 术后1和3个月曲安奈德组高眼压发生率高于地塞米松组(χ²=2.304、5.648,P<0.05),末次随访时两组高眼压发生率差异无统计学意义(χ²=0.006,P=0.941)。
关键数值与推荐
- 曲安奈德组术前眼压(8.58±3.83)mmHg vs 地塞米松组(6.70±2.49)mmHg(t=2.032,P<0.05)。
- 曲安奈德组术前脉络膜脱离高度0.90(0.00,3.84)mm vs 地塞米松组4.03(1.05,5.38)mm(Z=-2.569,P<0.05)。
- 曲安奈德组手术复位率95.7%(22/23) vs 地塞米松组76.0%(19/25)(χ²=2.304,P=0.129)。
- 末次随访最佳矫正视力曲安奈德组0.91±0.54 vs 地塞米松组1.25±0.62(t=-2.034,P=0.048)。
- 术后1和3个月高眼压发生率曲安奈德组高于地塞米松组(χ²=2.304、5.648,P<0.05);末次随访时两组差异无统计学意义(χ²=0.006,P=0.941)。
临床怎么用
- 原文结论指出后Tenon囊下注射曲安奈德行23G玻璃体切除术可提高眼压、降低脉络膜脱离高度并改善术后视力预后,但可能引起术后高眼压。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the efficiency of 23 G vitrectomy combined with preoperative subtenon injecfion of triamcinolone acetonide for treatment of rhegmatogenous retinal detachment associated with choroidal detachment. Methods: A retrospective analysis. Forty-eight (16 males and 32 females, aged 57.3±13.9) consecutive patients (48 eyes) who were diagnosed with rhegmatogenous retinal detachment associated with choroidal detachment and received 23 G vitrectomy at the Eye Hospital of Wenzhou Medical University during January 2012 and January 2015 were enrolled. Twenty-three eyes were treated with subtenon injection TA 5 d before the planned 23 G vitrectomy (TA group). Twenty-five eyes were treated with dexamethasone 3 to 5 d before the planned vitrectomy (Dex group). Type-B ultrasonic, intraocular pressure, best corrected visual acuity examinations were conducted for all eyes on admission day, preoperatively and at 1 month, 3 month postoperatively, and during the last visit. The rate of reattachment, change of height of choroidal detachment, intraocular pressure, best corrected visual acuity, and the complication of the eyes between the two groups were compared. All patients were followed up at least half a year after the repair surgery. Results: The intraocular pressure of the TA group was higher than the Dex group[(8.58±3.83)mmHg vs. (6.70±2.49)mmHg (1 mmHg=0.133 kPa), (t=2.032)], and the height of choroidal detachment was lower in TA group [0.90(0.00, 3.84)mm vs. 4.03(1.05, 5.38)mm, Z=-2.569, P<0.05]. There is no statistic difference between the reattachment rate of the two groups [95.7%(22/23) vs. 76.0%(19/25), χ(2)=2.304, P=0.129], but it seems it was better in TA group. The best corrected visual acuity results of the last visit was better in TA group than Dex group [(0.91±0.54) vs. (1.25±0.62), t=-2.034, P=0.048]. The rate of hypertention was higher in TA group than Dex group at 1 month, 3 month postoperatively(χ(2)=2.304, 5.648, P<0.05), while there was no statistic difference of hypertention rate during last visit between the two groups (χ(2)=0.006, P=0.941). Conclusions: The treatment of 23 G vitrectomy combined with subtenon injection of triamcinolone acetonide can improve the intraocular pressure, reduce the height of choroidal detachment, and improve the best corrected visual acuity after the surgery, but it may cause heyertenion. (Chin J Ophthalmol, 2018, 54: 252-257). 目的: 探讨后Tenon囊下注射曲安奈德后行23 G玻璃体切除术治疗脉络膜脱离型视网膜脱离的疗效。 方法: 回顾性病例对照研究。收集2012年1月至2015年1月在温州医科大学附属眼视光医院确诊为脉络膜脱离型视网膜脱离并接受23 G玻璃体切除术治疗的连续性病例48例(48只眼),其中男性16例(16只眼),女性32例(32只眼),平均年龄为(57.3±13.9)岁。23只眼术前后Tenon囊下注射曲安奈德(曲安奈德组),25只眼术前静脉滴注地塞米松10 mg/d(地塞米松组)。所有患者入院时、手术当天、术后1和3个月、末次随访均行B超、眼压、最佳矫正视力等检查,比较两组患者术前眼压、脉络膜脱离高度变化及手术复位率、视力改善情况、眼部并发症等,术后随访时间≥6个月。患者术前视力采用单因素方差分析进行比较,其余正态分布的计数资料采用t检验;计数资料采用卡方检验。 结果: 玻璃体切除术前,曲安奈德组和地塞米松组眼压分别为(8.58±3.83)和(6.70±2.49)mmHg(1 mmHg=0.133 kPa)(t=2.032),脉络膜脱离高度分别为0.90(0.00,3.84)和4.03(1.05,5.38)mm(Z=-2.569),差异均有统计学意义(P<0.05)。曲安奈德组患者手术复位率为95.7%(22/23),与地塞米松组的76.0%(19/25)相比,差异无统计学意义(χ(2)=2.304,P=0.129)。末次随访时曲安奈德组视力为0.91±0.54,优于地塞米松组的1.25±0.62(t=-2.034,P=0.048)。术后1和3个月时,曲安奈德组高眼压发生率较高(χ(2)=2.304,5.648;P<0.05),末次随访时差异无统计学意义(χ(2)=0.006,P=0.941)。 结论: 后Tenon囊下注射曲安奈德可提高眼压,降低脉络膜脱离高度,改善脉络膜脱离型视网膜脱离患者23 G玻璃体切除术后的视力预后,但可能会引起术后高眼压。(中华眼科杂志,2018,54:252-257).
引用
- Mao JB, Wu SL, Chen YQ, et al. [The efficiency of 23 G vitrectomy combined with preoperative subtenon injection of triamcinolone acetonide for treatment of retinal detachment associated with choroidal detachment]. Zhonghua Yan Ke Za Zhi. 2018. PMID: 29747353. doi:10.3760/cma.j.issn.0412-4081.2018.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。